Literature DB >> 25034898

Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.

Jennifer L Evans1, Meghan D Morris2, Michelle Yu2, Kimberly Page2, Judith A Hahn2.   

Abstract

INTRODUCTION: Young injection drug users (IDU, under age 30) often inject with other IDU, creating an environment for risk of blood-borne disease transmission through sharing of needles and drug preparation equipment. Epidemiologic studies rely on self reported injection behavior data for measures of transmission risk, therefore we sought to quantify the degree of concordance of reported injecting risk behaviors between injecting dyads.
METHODS: From May, 2006 through 2013 we enrolled 72 injecting dyads in San Francisco, California, who were hepatitis C virus (HCV) RNA discordant. Each partnership was followed prospectively for up to six months. Monthly interviews from each partner were date-matched and responses to relationship characteristics and risk behavior questions were compared. Concordance of reporting was estimated with the concordance correlation coefficient for longitudinal data (CCC) and the prevalence adjusted bias adjusted kappa (PABAK).
RESULTS: Participants had a median age of 26 (IQR: 23, 28) years and median years injecting of 7.0 (IQR: 3.0, 10.6). Thirty-eight percent of the injecting dyads were also sexual partners. Concordance levels were highest for partnership characteristics, such as length of acquaintance, number of days cohabitating, and sexual intercourse in the past month (CCC=0.95; 0.82, and 0.90, respectively). Shared injection risk behaviors such as injecting with the HCV+ partner's previously used syringe and using contaminated injection preparation equipment had slight to fair agreement (CCC=0.22; 0.23; PABAK=0.43, 0.36, respectively).
CONCLUSIONS: Concordance levels ranged from low to high. Potential sources of measurement error for low agreement items include recall and social-desirability biases and question interpretation. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Agreement; Drug users; Dyad; Epidemiology; Hepatitis C; Young adult

Mesh:

Year:  2014        PMID: 25034898      PMCID: PMC4471952          DOI: 10.1016/j.drugalcdep.2014.06.028

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  32 in total

1.  Recalling sexual partners: the accuracy of self-reports.

Authors:  James Jaccard; Robert McDonald; Choi K Wan; Vincent Guilamo-Ramos; Patricia Dittus; Shannon Quinlan
Journal:  J Health Psychol       Date:  2004-11

2.  Predictors of discordant reports of sexual and HIV/sexually transmitted infection risk behaviors among heterosexual couples.

Authors:  Susan S Witte; Nabila El-Bassel; Louisa Gilbert; Elwin Wu; Mingway Chang
Journal:  Sex Transm Dis       Date:  2007-05       Impact factor: 2.830

3.  Hepatitis C virus serosorting in people who inject drugs: sorting out the details.

Authors:  Arthur Y Kim; Kimberly Page
Journal:  J Infect Dis       Date:  2013-10-16       Impact factor: 5.226

4.  Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.

Authors:  Stephen Koester; Jason Glanz; Anna Barón
Journal:  AIDS Behav       Date:  2005-03

Review 5.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

6.  Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure.

Authors:  M Macaluso; L Lawson; R Akers; T Valappil; K Hammond; R Blackwell; G Hortin
Journal:  Contraception       Date:  1999-03       Impact factor: 3.375

Review 7.  Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior.

Authors:  J A Catania; D R Gibson; D D Chitwood; T J Coates
Journal:  Psychol Bull       Date:  1990-11       Impact factor: 17.737

8.  Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users.

Authors:  C A Latkin; D Vlahov; J C Anthony
Journal:  Addiction       Date:  1993-04       Impact factor: 6.526

9.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Authors:  Kimberly Page; Judith A Hahn; Jennifer Evans; Stephen Shiboski; Paula Lum; Eric Delwart; Leslie Tobler; William Andrews; Lia Avanesyan; Stewart Cooper; Michael P Busch
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

10.  Measuring agreement of administrative data with chart data using prevalence unadjusted and adjusted kappa.

Authors:  Guanmin Chen; Peter Faris; Brenda Hemmelgarn; Robin L Walker; Hude Quan
Journal:  BMC Med Res Methodol       Date:  2009-01-21       Impact factor: 4.615

View more
  3 in total

1.  Identification of Genetically Related HCV Infections Among Self-Described Injecting Partnerships.

Authors:  Damien C Tully; Judith A Hahn; David J Bean; Jennifer L Evans; Meghan D Morris; Kimberly Page; Todd M Allen
Journal:  Clin Infect Dis       Date:  2022-03-23       Impact factor: 20.999

2.  Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships.

Authors:  Judith A Hahn; Damien C Tully; Jennifer L Evans; Meghan D Morris; Alya Briceno; David J Bean; Todd M Allen; Kimberly Page
Journal:  Open Forum Infect Dis       Date:  2019-04-25       Impact factor: 3.835

3.  Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Authors:  Meghan D Morris; Jennifer Evans; Martha Montgomery; Michelle Yu; Alya Briceno; Kimberly Page; Judith A Hahn
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.